medigraphic.com

2016, Number S2

<< Back

Rev Med Inst Mex Seguro Soc 2016; 54 (S2)

Excessive spending by misuse of clinical laboratory

Benítez-Arvizu G, Novelo-Garza B, Mendoza-Valdez AL, Galván-Cervantes J, Morales-Rojas A

Language: Spanish
References: 20
Page: 216-223
PDF size: 260.97 Kb.


ABSTRACT

Seventy five percent or more of a diagnosis comes from a proper medical history along with an excellent physical examination. This leaves to the clinical laboratory the function of supporting the findings, determining prognosis, classifying the diseases, monitoring the diseases and, in the minimum of cases, establishing the diagnosis. In recent years there has been a global phenomenon in which the allocation of resources to health care has grown in an excessive way; the Instituto Mexicano del Seguro Social is not an exception with an increase of 29 % from 2009 to 2011; therefore, it is necessary to set containment and reduction without compromising the quality of patient care.


REFERENCES

  1. García-Raja A, Caballé-Martín I, Giménez-Marín A. Uso adecuado del laboratorio clínico: necesidad y tendencias. Rev Lab Clín. 2008;1(2):75-82.

  2. Guidelines and Audit Implementation Network (GAIN). Guidelines on the use of the Laboratory. Belfast, Northern Ireland: GAIN; 2008. Disponible en http://www.gain-ni.org/images/Uploads/Guidelines/ Lab_Guide.pdf

  3. Takemura Y, Beck J. Laboratory testing under managed care dominance in the USA. J Clin Pathol. 2001;54(2):89-95. doi: 10.1136/jcp.54.2.89

  4. Fryer AA, Smellie WS. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol. 2013 Jan;66(1):62-72. doi: 10.1136/jclinpath-2011-200524.

  5. Robinson A. Rationale for cost-effective laboratory medicine. Clin Microbiol Rev. 1994 Apr;7(2):185-99.

  6. Rodríguez-Espinosa J. El laboratorio clínico: uso y abuso, modelos de gestión y gasto sanitario. Med Clin (Barc). 2005;125(16):622-5. doi: 10.1157/13080838

  7. Department of Health (England). Report of the Second Phase of the Review of NHS Pathology Services in England. Chaired by Lord Carter of Coles. London: Department of Health; 2008. Disponible en http://webarchive.nationalarchives.gov. uk/20130107105354/http:/www.dh.gov.uk/prod_ consum_dh/groups/dh_digitalassets/@dh/@en/ documents/digitalasset/dh_091984.pdf

  8. Whiting P, Toerien M, de Salis I, Sterne JA, Dieppe P, Egger M, et al. A review identifies and classifies reasons for ordering diagnostic tests. J Clin Epidemiol. 2007 Oct;60(10):981-9.

  9. Smellie WSA. Appropriateness of test use in pathology: a new era or reinventing the wheel? Ann Clin Biochem. 2003;40:585-92

  10. Barth JH. Selecting clinical quality indicators for laboratory medicine. Ann Clin Biochem. 2012 May;49(Pt 3):257-61. doi: 10.1258/acb.2011.011159.

  11. Emerson JF, Emerson SS. The impact of requisition design on laboratory utilization. Am J Clin Pathol. 2001 Dec;116(6):879-84.

  12. Plebani M1, Sciacovelli L, Marinova M, Marcuccitti J, Chiozza ML. Quality indicators in laboratory medicine: a fundamental tool for quality and patient safety. Clin Biochem. 2013 Sep;46(13-14):1170-4. doi: 10.1016/j.clinbiochem.2012.11.028.

  13. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med. 2013 Apr;51(4):741-51. doi: 10.1515/cclm-2013-0075.

  14. Plebani M, Chiozza ML, Sciacovelli L. Towards harmonization of quality indicators in laboratory medicine. Clin Chem Lab Med. 2013 Jan;51(1):187-95. doi: 10.1515/cclm-2012-0582.

  15. Instituto Mexicano del Seguro Social (IMSS). Informe de Labores y Programa de Actividades 2012-2013. Distrito Federal, México: IMSS; 2013. Disponible en http://www.imss.gob.mx/sitesall/statics/ pdf/informes/2013/2013_InformeLabores 2012- 2013.pdf

  16. Instituto Mexicano del Seguro Social (IMSS). Informe al Ejecutivo Federal y al Congreso de la Unión sobre la situación financiera y los riesgos del Instituto Mexicano del Seguro Social 2011-2012. Distrito Federal, México: IMSS; 2012. Disponible en http://www.imss. gob.mx/sites/all/statics/pdf/informes/2012/2012_InformeEjecutivo2011- 2012.pdf

  17. Instituto Mexicano del Seguro Social (IMSS). Norma que establece las disposiciones para la aplicación de los programas integrados de salud PREVENIMSS en el Instituto Mexicano del Seguro Social. Norma 2000-0001-019. Distrito Federal, México; 2011. Disponible en http://www.imss.gob.mx/sites/ all/statics/pdf/manualesynormas/2000-001-019.pdf

  18. Greenblatt MB, Nowak JA, Quade CC, Tanasijevic M, Lindeman N, Jarolim P. Impact of a prospective review program for reference laboratory testing requests. Am J Clin Pathol. 2015 May;143(5):627-34. doi: 10.1309/AJCPN1VCZDVD9ZVX.

  19. Procop GW, Keating C, Stagno P, Kottke-Marchant K, Partin M, Tuttle R, et al. Reducing duplicate testing: a comparison of two clinical decision support tools. Am J Clin Pathol. 2015 May;143(5):623-6. doi: 10.1309/AJCPJOJ3HKEBD3TU.

  20. Wilson ML. Decreasing inappropriate laboratory test utilization: controlling costs and improving quality of care. Am J Clin Pathol. 2015;143:614-16.




2020     |     www.medigraphic.com